Compugen Ltd. Stock
Price
Target price
€1.58
€1.58
7.520%
0.108
7.520%
€3.69
08.07.24 / Tradegate
WKN: 553001 / Symbol: CGEN / Name: Compugen / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Compugen Ltd. Stock
Compugen Ltd. dominated the market today, gaining €0.11 (7.520%).
Currently there is a rather positive sentiment for Compugen Ltd. with 5 Buy predictions and 2 Sell predictions.
As a result the target price of 3 € shows a very positive potential of 90.36% compared to the current price of 1.58 € for Compugen Ltd..
Pros and Cons of Compugen Ltd. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Compugen Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Compugen Ltd. | 7.520% | - | - | - | - | - | - |
| Protalix Biotherapeutics Inc. | -0.940% | -0.691% | -15.320% | -32.821% | -38.864% | -30.621% | -73.526% |
| Organovo Holdings Inc. | -3.280% | -11.470% | -27.417% | -67.991% | -46.589% | -91.923% | -93.858% |
| Intellia Therapeutics Inc | -0.130% | -2.537% | 1.766% | -40.852% | -20.380% | -82.208% | 51.745% |
Comments
Compugen Ltd. (NASDAQ: CGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target lowered by analysts at Truist Financial Co. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for CGEN provided by MarketBeat